Researchmoz added Most up-to-date research on "Exosome Technologies: Recent Surge in R&D with Capricor, Codiak and Evox Therapeutics among Key Players" to its huge collection of research reports.
GBI Research’s latest report, Exosome Technologies: Recent Surge in R&D with Capricor, Codiak and Evox Therapeutics among Key Players, explores the application of exosome technologies within the pharmaceutical and healthcare industries. Exosomes are small cell-derived vesicles that are abundant in bodily fluids, including blood, urine and cerebrospinal fluid as well as in in vitro cell culture.
Get Free PDF Brochure For More Technical Insights@ https://www.researchmoz.us/enquiry.php?type=S&repid=1935556
These vesicles are being used in a variety of therapeutic applications, including as therapeutic biomarkers, drug delivery systems and therapies in their own right. Research within this area remains in the nascent stages, although a number of clinical trials have been registered within the field. Exosomes have several diverse therapeutic applications, largely centering on stem cell and gene therapy. Exosomes have been identified as endogenous carriers of RNA within the body, allowing for the intercellular transportation of genetic material to target cells.
As such, developers have worked to engineer exosomes for the delivery of therapeutic miRNA and siRNA-based gene therapies. As RNA is highly unstable within the body, a number of different biologic vector systems have been developed to enhance their transport within the circulation, including viruses and liposomes. Similarly, exosomes derived from stem cells have also been identified for their therapeutic applications, particularly in the treatment of cancer and cardiovascular disease. Exosome technologies offer several advantages over existing biologic-based drug delivery systems.
They have a long circulatory half-life as a result of their high stability and ability to avoid breakdown by the mononuclear phagocyte system and reticuloendothelial systems. Moreover, exosomes have several functional properties that favor their use in therapeutic delivery. Exosomes can be engineered to incorporate targeting ligands, allowing them to deliver cargo selectively to cells. Their small size allows them to penetrate the blood-brain barrier for the delivery of central nervous system therapies, whereas in cancer they can accumulate within the tumor via enhanced permeability and retention effects.
View Complete TOC with tables & Figures @ https://www.researchmoz.us/exosome-technologies-recent-surge-in-rd-with-capricor-codiak-and-evox-therapeutics-among-key-players-report.html/toc
Finally, clinical trials have shown relatively large-scale production to be possible and indicate that exosome therapies can be safely administered to humans. Additionally, exosomes are being investigated for their potential as prognostic and diagnostic biomarkers for several different disease indications. Exosomes make good candidates for biomarker research because of two unique characteristics: their presence in various accessible bodily fluids, and their resemblance to their parent cells of origin. R&D in exosome technologies has increased markedly in recent years. This report provides detailed information on the various healthcare applications of exosomes, and assesses the pipeline, clinical trial and company landscapes.
List of Chart:
Figure 1: Exosome Technologies, Global, Pipeline by Stage of Development and Molecule Type, 2018 37
Figure 2: Exosome Technologies, Global, Pipeline by Therapy Area, 2018 38
Figure 3: Exosome Technologies, Global, List of All Pipeline Programs Involving Exosomes, 2018 (part 1) 46
Figure 4: Exosome Technologies, Global, List of All Pipeline Programs Involving Exosomes, 2018 (part 2) 47
Figure 5: Exosome Technologies, Global, Clinical Trials by Study Design, 2006-2025 48
Figure 6: Exosome Technologies, Global, Interventional Clinical Trials by Therapy Type, 2006-2022 49
Figure 7: Exosome Technologies, Global, Interventional Clinical Trials by Therapy Area, 2006-2022 49
Figure 8: Exosome Technologies, Global, Interventional Clinical Trials by Stage of Development, 2006-2022 50
Figure 9: Exosome Technologies, Global, Interventional Clinical Trials by Year, 2006-2022 51
Figure 10: Exosome Technologies, Global, Observational Trials by Therapy Area, 2011-2025 52
Figure 11: Exosome Technologies, Global, Observational Trials by Therapy Area, 2011-2025 52
Make An Enquiry @ https://www.researchmoz.us/enquiry.php?type=E&repid=1935556
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us ;
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow us on Blogger at : https://marketreportandanalysis.blogspot.com
GBI Research’s latest report, Exosome Technologies: Recent Surge in R&D with Capricor, Codiak and Evox Therapeutics among Key Players, explores the application of exosome technologies within the pharmaceutical and healthcare industries. Exosomes are small cell-derived vesicles that are abundant in bodily fluids, including blood, urine and cerebrospinal fluid as well as in in vitro cell culture.
Get Free PDF Brochure For More Technical Insights@ https://www.researchmoz.us/enquiry.php?type=S&repid=1935556
These vesicles are being used in a variety of therapeutic applications, including as therapeutic biomarkers, drug delivery systems and therapies in their own right. Research within this area remains in the nascent stages, although a number of clinical trials have been registered within the field. Exosomes have several diverse therapeutic applications, largely centering on stem cell and gene therapy. Exosomes have been identified as endogenous carriers of RNA within the body, allowing for the intercellular transportation of genetic material to target cells.
As such, developers have worked to engineer exosomes for the delivery of therapeutic miRNA and siRNA-based gene therapies. As RNA is highly unstable within the body, a number of different biologic vector systems have been developed to enhance their transport within the circulation, including viruses and liposomes. Similarly, exosomes derived from stem cells have also been identified for their therapeutic applications, particularly in the treatment of cancer and cardiovascular disease. Exosome technologies offer several advantages over existing biologic-based drug delivery systems.
They have a long circulatory half-life as a result of their high stability and ability to avoid breakdown by the mononuclear phagocyte system and reticuloendothelial systems. Moreover, exosomes have several functional properties that favor their use in therapeutic delivery. Exosomes can be engineered to incorporate targeting ligands, allowing them to deliver cargo selectively to cells. Their small size allows them to penetrate the blood-brain barrier for the delivery of central nervous system therapies, whereas in cancer they can accumulate within the tumor via enhanced permeability and retention effects.
View Complete TOC with tables & Figures @ https://www.researchmoz.us/exosome-technologies-recent-surge-in-rd-with-capricor-codiak-and-evox-therapeutics-among-key-players-report.html/toc
Finally, clinical trials have shown relatively large-scale production to be possible and indicate that exosome therapies can be safely administered to humans. Additionally, exosomes are being investigated for their potential as prognostic and diagnostic biomarkers for several different disease indications. Exosomes make good candidates for biomarker research because of two unique characteristics: their presence in various accessible bodily fluids, and their resemblance to their parent cells of origin. R&D in exosome technologies has increased markedly in recent years. This report provides detailed information on the various healthcare applications of exosomes, and assesses the pipeline, clinical trial and company landscapes.
List of Chart:
Figure 1: Exosome Technologies, Global, Pipeline by Stage of Development and Molecule Type, 2018 37
Figure 2: Exosome Technologies, Global, Pipeline by Therapy Area, 2018 38
Figure 3: Exosome Technologies, Global, List of All Pipeline Programs Involving Exosomes, 2018 (part 1) 46
Figure 4: Exosome Technologies, Global, List of All Pipeline Programs Involving Exosomes, 2018 (part 2) 47
Figure 5: Exosome Technologies, Global, Clinical Trials by Study Design, 2006-2025 48
Figure 6: Exosome Technologies, Global, Interventional Clinical Trials by Therapy Type, 2006-2022 49
Figure 7: Exosome Technologies, Global, Interventional Clinical Trials by Therapy Area, 2006-2022 49
Figure 8: Exosome Technologies, Global, Interventional Clinical Trials by Stage of Development, 2006-2022 50
Figure 9: Exosome Technologies, Global, Interventional Clinical Trials by Year, 2006-2022 51
Figure 10: Exosome Technologies, Global, Observational Trials by Therapy Area, 2011-2025 52
Figure 11: Exosome Technologies, Global, Observational Trials by Therapy Area, 2011-2025 52
Make An Enquiry @ https://www.researchmoz.us/enquiry.php?type=E&repid=1935556
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us ;
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow us on Blogger at : https://marketreportandanalysis.blogspot.com
No comments:
Post a Comment